07/07/2022 - Covid-19
A study on the vaccine response of patients with primary antibody deficiency carried out by the Functional Unit of Primary Immunodeficiencies at Hospital del Mar together with the dibi Network (Reference Laboratory of Catalonia) has revealed that a good number of these people have antibodies against SARS-CoV-2 without actually having contracted COVID-19. The study, published in the journal Immunology, is the first to certify the transmission of antinucleocapsid antibodies (ANC) from donors to patients with primary immunodeficiency.
18/05/2022 - Covid-19
A study by doctors and researchers at Hospital del Mar and the Hospital del Mar Medical Research Institute confirms that COVID-19 infection is much more virulent than the flu in this group of patients, despite the fact that they are younger and in better health. They also require longer hospital stays and more care. This means that the price of their treatment is double that of patients admitted for influenza, with an extra cost of almost 10,000 euros. The study has been published in the journal Clinical Infectious Diseases and presented at the European Congress of Microbiology and Infectious Diseases held in Lisbon.
22/02/2022 - Covid-19
Dr. Esther Barreiro is the editor of the book 'Physiopathology of COVID-19 in different organs and systems', published by Elsevier. It is a work and study manual for people interested in learning more about this disease. The experts from Hospital del Mar have played a leading role in the new publication by Elsevier, Physiopathology of COVID-19 in different organs and systems, the first manual that analyses, with the help of various specialists, the effects caused by SARS-CoV-2, its mechanisms of infection, treatment, and sequelae. Dr. Esther Barreiro, consultant physician in the Pneumology Department at Hospital del Mar, researcher at the Hospital del Mar Medical Research Institute (IMIM), and associate professor at Pompeu Fabra University, is the editor.
21/01/2022 - Covid-19
12% of patients admitted for COVID-19 who also suffer heart damage need to be readmitted or die within the first year after recovering from the disease. In contrast, this occurs in only 1% of those who do not suffer heart damage during the SARS-CoV-2 infection, according to a study published in the Journal of Clinical Medicine. These people have a baseline situation that is aggravated by previous pathologies such as high blood pressure, chronic renal failure and episodes of heart failure. The authors of the study recommend routine screening for heart damage markers in the blood of patients admitted for COVID-19 to be able to carefully monitor these problems in the long term. Patients who suffer heart damage during a COVID-19 infection are more likely to need to be readmitted to hospital or to die than those who survive the disease without suffering this. This has been revealed by a study led by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER in Cardiovascular Diseases (CIBERCV), which has been published in the Journal of Clinical Medicine.
Més informació "Cardiac damage in COVID-19 patients is an indicator of poor long-term prognosis"
29/12/2021 - Covid-19
Patients with type-2 diabetes affected by COVID-19 are four to five times more likely to die or suffer serious complications from the disease if their blood sugar levels are much higher or much lower than usual This has been revealed in a study led by the Endocrinology and Nutrition Service at Hospital del Mar and published in the journal Diabetes Care The ratio of glucose levels on arrival in the emergency room to the patient's usual levels has a high predictive value, more so than either of the two data separately. These levels can be determined easily through a blood test
23/11/2021 - Covid-19
The data comes from more than 90,000 people diagnosed with COVID-19 in Catalonia up to July last year. More than 6% had suffered a stroke at some point before infection. People under the age of 60 who have suffered a stroke prior to contracting COVID-19 are three times more likely to die than those who have never suffered a stroke. This risk drops to 1.3 times in people aged between 60 and 80 and is not significant in those over 80 The researchers point out that this needs to be taken into account when determining COVID-19 vaccination priorities. The study is published in the journal Stroke. It is the first study of its kind in Spain and one of the first in the world.
10/03/2021 - Covid-19
MINDCOVID, a project led by the Research Group on Health Services of the Hospital del Mar Medical Research Institute (IMIM) presents its new website. It is a statewide project, in which more than 20 research groups from 6 autonomous communities collaborate, and its objective is to study the mental health of healthcare workers and other essential groups, as well as in patients with COVID-19 and also in a sample of the Spanish general population. MINDCOVID aims to provide a comprehensive assessment of the impact on mental health of the current outbreak of COVID-19 in Spain, and to be a follow-up project to monitor mental health changes over time in the groups studied. On the project's website you will find all the necessary information about the project, the team of professionals and researchers who collaborate with it, as well as information on the latest publications, questionnaires, reports, documentation on the protocol and the latest news and advances in research being conducted.
04/03/2021 - Covid-19
Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease. These are the findings of a study by physicians and researchers from the Hospital del Mar, Hospital del Mar Medical Research Institute (IMIM) and Pompeu Fabra University (UPF), led by Dr. Robert Güerri, a physician at the Infectious Diseases Service of Hospital del Mar, which has just been published in the journal Nutrients. The study analysed the zinc levels of 249 adult patients treated at the centre between 9 March and 1 April 2020, with an average age of 65 years. The most common symptoms presented at the time of admission were fever, cough and dyspnea.
Més informació "Administering zinc to covid-19 patients could help towards their recovery"
18/02/2021 - Covid-19
The Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, the University of California-Davis and the University of Texas have launched a clinical trial to analyse how useful a food supplement can be for preventing the worst side effects of COVID-19. The study is looking at bovine-derived immunoglobulins, which have been shown in animal models to reduce the inflammation caused by infection, progression to more severe forms of the disease, and post-COVID syndrome. The first patients participating in the Randomized Open-Label Clinical Study Evaluating the Impact of EnteraGam, a Nutritional Intervention containing Bovine Plasma-Derived Immunoglobulin CoNcentrate, on Clinical Outcomes In People with COVID19 (PICNIC Study) are already taking two daily doses of this supplement. Dr Robert Güerri, principal investigator in the trial, member of the Infectious Pathology and Antimicrobial Research Group at the IMIM-Hospital del Mar, and section head of the Infectious Diseases Service at Hospital del Mar, explains that "The aim of the treatment is to sequester and help eliminate the virus from one of its main reservoirs in the body, the gut."
Més informació "Immunoglobulin clinical trial launched to prevent COVID-19 side effects"
02/02/2021 - Covid-19
The effects of the lockdown decreed to deal with the COVID-19 pandemic on the mental health of elderly people in pre-dementia stages were protracted during the de-escalation phase. This is highlighted by a study published in the Journal of Alzheimer's Disease, led by researchers from the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar, as well as researchers from the CIBER on the Physiopathology of Obesity and Nutrition (CIBEROBN) and the CIBER on Fragility and Healthy Ageing (CIBERFES). The work was carried out in collaboration with the Barcelona βeta Brain Research Center (BBRC). The study involved monitoring sixteen people, between 60 and 80 years old, who are participants in the PIENSA study on the prevention of cognitive deterioration in the stages prior to the onset of dementia. None of them suffered COVID-19. Their activity was exhaustively monitored on a daily, weekly, and monthly basis for two months, which made it possible to compare their progression before, during and after lockdown.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
